Research brief
How Many Doses in an Adamax Vial? (Storage & Usage Guide)
Short answer
The yield from an Adamax vial isn't fixed. It's entirely determined by three variables most researchers overlook until they've already reconstituted incorrectly: the vial's stated peptide mass (typically 5mg or 10mg lyophilized powder), the volume of bacteriostatic water used for reconstitution, and the target dose per injection. A 10mg vial reconstituted with 2mL bacteriostatic water yields a 5mg/mL concentration.
Key takeaways
- A 10mg Adamax vial reconstituted with 2mL bacteriostatic water yields 10–20 doses depending on target concentration (0.5mg vs 1mg per injection).
- Dose count is calculated from peptide mass divided by reconstitution volume and target dose. It is not a fixed vial specification.
- Reconstituted peptide solutions remain stable for 28 days when stored at 2–8°C; beyond this window, protein denaturation occurs regardless of visual appearance.
- Concentration affects dosing accuracy: 5mg/mL (from 10mg + 2mL) allows precise measurement with standard insulin syringes, while concentrations above 10mg/mL increase dosing error risk.
- Lyophilized powder vials must be stored at −20°C before reconstitution; temperature excursions above 25°C for extended periods degrade peptide structure irreversibly.
The yield from an Adamax vial isn't fixed. It's entirely determined by three variables most researchers overlook until they've already reconstituted incorrectly: the vial's stated peptide mass (typically 5mg or 10mg lyophilized powder), the volume of bacteriostatic water used for reconstitution, and the target dose per injection. A 10mg vial reconstituted with 2mL bacteriostatic water yields a 5mg/mL concentration. Meaning each 0.1mL (100mcg on an insulin syringe) delivers 0.5mg peptide. At 0.5mg per dose, that's 20 injections. At 1mg per dose, it's 10 injections. The math is straightforward once you understand the concentration formula. But pre-reconstitution, most vials look identical regardless of peptide mass.
Our team has worked extensively with research-grade peptide reconstitution protocols. The single most common error we've observed isn't contamination or improper storage. It's researchers calculating dose count based on vial volume rather than stated peptide mass, leading to significant under-dosing or over-dosing across multi-week studies.
How many usable doses does a standard Adamax vial contain after reconstitution?
A standard 10mg Adamax vial reconstituted with 2mL bacteriostatic water yields 10–20 research doses depending on target concentration. At 0.5mg per dose (common for initial protocols), the vial delivers 20 injections. At 1mg per dose (common for maintenance or higher-intensity studies), it delivers 10 injections. The peptide remains stable for 28 days when refrigerated at 2–8°C post-reconstitution. Any unused solution beyond this window undergoes protein denaturation that renders it ineffective regardless of appearance.
Most guides explain reconstitution mechanics but skip the practical implication: dose count per vial is a calculated output, not a product specification. Adamax isn't sold as 'X doses per vial' because dosing protocols vary widely across research applications. A 5mg vial used at 0.25mg per dose yields 20 injections. The same count as a 10mg vial at 0.5mg per dose. The math changes with every variable. This article covers exactly how to calculate dose yield from stated peptide mass, how reconstitution volume affects concentration and usability, and what storage errors silently destroy peptide integrity before you realize the vial has degraded.
Understanding Adamax Vial Specifications and Peptide Mass
Adamax is supplied as lyophilized (freeze-dried) powder in sealed sterile vials. Typically at 5mg or 10mg peptide mass per vial. The number printed on the vial label represents total peptide content in milligrams, not dose count or volume. A 10mg vial contains 10,000 micrograms of peptide in powder form. Once reconstituted with bacteriostatic water, that 10mg is dissolved into whatever volume you add. Commonly 1mL, 2mL, or 3mL depending on desired final concentration. The resulting solution's concentration (mg/mL) determines how much peptide is delivered per unit volume drawn into a syringe.
Example calculation: 10mg peptide powder + 2mL bacteriostatic water = 5mg/mL solution. Each 0.1mL of that solution contains 0.5mg peptide. If your protocol calls for 0.5mg per injection, each 0.1mL draw is one dose. Yielding 20 total doses from the 2mL vial. If the protocol requires 1mg per injection, you draw 0.2mL per dose. Yielding 10 total doses from the same vial. The peptide mass is fixed; dose count is derived.
This is where confusion arises. Researchers accustomed to pre-filled pharmaceutical pens (which deliver fixed doses per click) often expect peptide vials to function similarly. But research-grade lyophilized peptides require manual calculation at every step. Real Peptides supplies Adamax with Certificate of Analysis documentation verifying peptide purity and mass per vial, but dosing decisions remain protocol-dependent. A 10mg vial used in a study requiring 0.25mg daily doses yields 40 injections. The same vial used at 2mg weekly doses yields 5 injections. The vial doesn't change. The application does.
Reconstitution Math: How Volume Determines Concentration
Reconstitution volume is the single most important variable for calculating doses per vial. The concentration formula is: Concentration (mg/mL) = Peptide Mass (mg) ÷ Reconstitution Volume (mL). A 10mg vial reconstituted with 1mL water yields 10mg/mL. The same vial reconstituted with 2mL yields 5mg/mL. The same vial with 4mL yields 2.5mg/mL. Lower concentrations are easier to dose accurately at small increments but occupy more refrigerator space and degrade slightly faster due to increased surface area exposure.
Most insulin syringes (the standard tool for subcutaneous peptide injection) are graduated in 0.01mL increments up to 1mL total capacity. At 10mg/mL concentration, drawing 0.05mL delivers 0.5mg peptide. A precise dose but requiring careful measurement at the lower end of syringe graduations. At 5mg/mL concentration, 0.5mg requires drawing 0.1mL. Easier to measure accurately and less prone to dosing error. This is why 2mL reconstitution volume (yielding 5mg/mL from a 10mg vial) is the most common standard: it balances concentration high enough to minimize injection volume with dilution sufficient for accurate syringe measurement.
Our experience with peptide protocols shows that researchers who reconstitute at concentrations above 10mg/mL often encounter dosing inconsistencies. The required draw volumes fall below reliable syringe precision. Conversely, reconstituting a 10mg vial with 5mL or more creates a solution so dilute that therapeutic doses require injecting 0.5mL or more per administration, which increases injection site discomfort and introduces more bacteriostatic water than necessary. The 2–3mL range hits the usability sweet spot for most applications requiring 0.25–1mg per dose.
Doses Vial Adamax: Standard Yield by Reconstitution Volume
| Vial Size | Reconstitution Volume | Final Concentration | Dose per 0.1mL | Total Doses at 0.5mg | Total Doses at 1mg |
|---|---|---|---|---|---|
| 5mg | 1mL | 5mg/mL | 0.5mg | 10 | 5 |
| 5mg | 2mL | 2.5mg/mL | 0.25mg | 20 | 10 |
| 10mg | 1mL | 10mg/mL | 1mg | 20 | 10 |
| 10mg | 2mL | 5mg/mL | 0.5mg | 20 | 10 |
| 10mg | 3mL | 3.33mg/mL | 0.33mg | 30 | 15 |
This table shows dose yield assuming full vial usage within 28-day refrigerated stability window. Actual usable doses may be slightly lower due to dead volume in vial neck and syringe hub. Typically 0.1–0.2mL total loss across the protocol. For a 2mL reconstituted vial, this represents approximately one dose lost to mechanical waste.
What If: Adamax Dosing Scenarios
What If I Reconstituted with the Wrong Volume?
Recalculate your concentration immediately using the formula: peptide mass ÷ actual volume added. If you intended 2mL but added 3mL, your 10mg vial now yields 3.33mg/mL instead of 5mg/mL. Meaning you must draw 0.15mL (150 units on an insulin syringe) to achieve a 0.5mg dose instead of 0.1mL. The solution is still usable; you simply adjust draw volume to match the new concentration. Do not attempt to remove excess water from the vial or add more peptide powder. Both create contamination risk and concentration inconsistency.
What If the Vial Contains Slightly More or Less Than 2mL After Reconstitution?
This is normal. Lyophilized peptide powder occupies minimal volume (typically 0.05–0.1mL when dissolved), so adding 2mL bacteriostatic water yields slightly more than 2mL final solution. Usually 2.05–2.1mL. The concentration calculation assumes the added water volume, not final solution volume, because peptide mass is fixed. For practical purposes, treat a vial reconstituted with 2mL water as 5mg/mL concentration even if total liquid measures 2.08mL. The difference is within normal margin and does not meaningfully affect dosing accuracy across a 10–20 dose protocol.
What If I Need More Than 20 Doses from a Single Vial?
You cannot extract more peptide than the vial contains. A 10mg vial yields exactly 10mg total peptide regardless of how it's diluted. If your protocol requires 0.25mg per dose, reconstitute with 2mL to yield 5mg/mL. Each 0.05mL draw delivers 0.25mg, yielding 40 total doses. If 0.25mg doses still don't provide enough injections for your study duration, you need multiple vials. Research protocols requiring daily dosing over 8+ weeks commonly use 2–3 vials sequentially rather than attempting to stretch a single vial beyond its 28-day post-reconstitution stability window.
The Practical Truth About Adamax Vial Shelf Life
Here's the honest answer: most peptide degradation happens during storage. Not during reconstitution or injection. Lyophilized Adamax stored at −20°C remains stable for 12–24 months. Once reconstituted with bacteriostatic water, that window drops to 28 days at 2–8°C. The 28-day limit isn't arbitrary. It's the point at which bacterial growth in the solution (even with bacteriostatic water) and peptide oxidation from ambient oxygen exposure begin to meaningfully compromise structural integrity. Beyond 28 days, the solution may look clear and sterile, but binding affinity to target receptors declines measurably.
The mistake researchers make is treating the 28-day window as a soft guideline rather than a hard cutoff. A vial reconstituted 35 days ago isn't 'probably still fine'. It's chemically compromised in ways home testing cannot detect. Potency loss is gradual and invisible until you retrospectively realize your later-protocol results diverge from earlier baselines. If you cannot use a full vial within 28 days, reconstitute smaller peptide masses or use lower-dose protocols that exhaust the vial faster. Stretching a single 10mg vial across 12 weeks by using it sparingly guarantees the final doses deliver significantly less active peptide than the first doses. Introducing a confounding variable into any study relying on dose consistency.
Waste from unused reconstituted solution isn't a protocol failure. It's a quality control measure. Discard any solution older than 28 days even if volume remains. The integrity of your data depends on it.
Unreconstituted lyophilized vials are the safest long-term storage form. If you order multiple vials, keep them sealed at −20°C and reconstitute only one at a time as needed. A frozen lyophilized vial maintains full potency for 18+ months. A reconstituted vial in the refrigerator begins degrading on day one. Temperature consistency matters as much as absolute temperature. Every time a vial sits at room temperature during dosing (which should be under 5 minutes), degradation accelerates slightly. This is why reconstituted peptide protocols emphasize returning vials to refrigeration immediately after each draw.
Temperature excursions are peptide's silent killer. A vial left on a counter for 3 hours, or transported without a cold pack, or stored in a refrigerator that cycles above 10°C during defrost. All scenarios that don't visibly alter the solution but irreversibly denature the peptide structure. If you're uncertain whether a vial experienced a temperature breach, assume it did. The cost of replacing a compromised vial is far lower than the cost of running an entire protocol on degraded material without realizing results are skewed.
Using research-grade peptides means understanding that dose count per vial is secondary to dose quality per injection. A vial that yields 15 high-integrity doses outperforms a vial stretched to 25 degraded doses every time. Calculate your doses conservatively, store meticulously, and discard ruthlessly when stability windows expire.
Frequently Asked Questions
How many doses are in a 10mg Adamax vial?
A 10mg Adamax vial yields 10–40 doses depending on reconstitution volume and target dose per injection. At 0.5mg per dose (common baseline), reconstituting with 2mL bacteriostatic water produces 20 injections. At 1mg per dose, the same vial delivers 10 injections. At 0.25mg per dose, it yields 40 injections. The peptide mass is fixed at 10mg. Dose count is derived from concentration and protocol requirements.
Can I store a reconstituted Adamax vial for longer than 28 days?
No. Reconstituted peptide solutions degrade beyond 28 days even when refrigerated at 2–8°C due to peptide oxidation and reduced bacteriostatic effectiveness. The solution may remain visually clear, but binding affinity declines measurably. Compromising dose consistency across extended protocols. Any reconstituted vial older than 28 days should be discarded and replaced with freshly reconstituted material to maintain research integrity.
What happens if I accidentally freeze a reconstituted Adamax vial?
Freezing reconstituted peptide solutions causes ice crystal formation, which physically disrupts peptide tertiary structure. Rendering the solution ineffective even after thawing. Unlike lyophilized powder (which is freeze-dried and designed to withstand freezing), liquid peptide solutions must remain between 2–8°C. If a reconstituted vial freezes, discard it. The structural damage is irreversible and cannot be detected visually.
How do I calculate the correct draw volume for a specific dose?
Use the formula: Draw Volume (mL) = Target Dose (mg) ÷ Concentration (mg/mL). If your vial is 5mg/mL and you need 0.5mg, divide 0.5 by 5 to get 0.1mL (or 10 units on a 100-unit insulin syringe). If your vial is 10mg/mL and you need 1mg, divide 1 by 10 to get 0.1mL. Always verify your concentration before each draw. Label the vial with final concentration immediately after reconstitution to prevent calculation errors mid-protocol.
Should I reconstitute multiple vials at once or one at a time?
Reconstitute one vial at a time unless your protocol requires overlapping vials within the same 28-day window. Multiple reconstituted vials create unnecessary degradation risk and refrigerator space constraints. Lyophilized powder stored at −20°C remains stable for 12–24 months, so there's no advantage to reconstituting in advance. Plan reconstitution timing so each vial is fully used within 28 days before opening the next sealed vial.
What is the difference between bacteriostatic water and sterile water for reconstitution?
Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth in multi-dose vials. Extending safe usage to 28 days post-reconstitution when refrigerated. Sterile water lacks this preservative and should only be used for single-dose immediate administration. Using sterile water for a vial you plan to dose from repeatedly over weeks creates contamination risk. All Adamax reconstitution should use pharmaceutical-grade bacteriostatic water to maintain sterility across the full protocol duration.
Can I mix Adamax with other peptides in the same vial?
No. Mixing different peptides in the same reconstituted solution creates unpredictable interactions. Peptides may bind to each other, precipitate, or degrade at different rates. Each peptide should be reconstituted in its own dedicated vial and drawn separately even if administered in the same protocol session. Co-administration requires separate syringes and separate injection sites to maintain dosing accuracy and prevent cross-contamination.
How do I know if my Adamax vial has degraded?
Visual inspection is unreliable. Degraded peptide solutions often remain clear and colorless. The only reliable indicators are protocol timeline (discard after 28 days post-reconstitution) and storage compliance (discard if temperature exceeded 8°C for more than 2 hours total). Cloudiness, discoloration, or visible particles indicate severe contamination or precipitation and require immediate disposal, but absence of these signs does not confirm integrity. Assume degradation has occurred if storage protocols were not followed meticulously.
What is the standard dose range for Adamax in research protocols?
Adamax research protocols typically use 0.25–2mg per injection depending on study objectives and subject parameters. Initial titration often begins at 0.25–0.5mg to assess tolerance, with maintenance doses ranging from 0.5–1mg. Higher doses (1–2mg) are used in specific applications requiring intensified receptor activation. Dosing frequency is commonly daily or every other day. Weekly protocols are uncommon with Adamax due to its relatively short half-life compared to longer-acting peptides.
Can I travel with reconstituted Adamax vials?
Yes, but temperature control is critical. Reconstituted vials must remain between 2–8°C during transport. Use a medical-grade insulin cooler or cold pack system rated for 24–48 hour temperature maintenance. Avoid standard ice packs that freeze the solution. Freezing destroys peptide structure. For air travel, reconstituted vials may trigger additional screening; carry documentation verifying research use and bacteriostatic water composition to expedite security clearance.
Adamax vial yield comes down to three fixed variables: stated peptide mass, reconstitution volume, and target dose per injection. A 10mg vial is exactly that. 10mg total peptide that you divide across however many doses your protocol requires. The math is straightforward once you calculate concentration; the challenge is maintaining that integrity across the 28-day post-reconstitution window. Researchers who understand this distinction. Between peptide quantity and peptide quality. Design protocols that prioritize consistent dose delivery over maximum vial extraction. If reconstitution math feels uncertain, explore Real Peptides' full research-grade peptide collection. Every product includes Certificate of Analysis documentation and detailed reconstitution guidance to support protocol precision from vial one.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA